NCT04545801View on ClinicalTrials.gov

Ketamine for Analgesia After Cesarean Section

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

March 31, 2019

Study Completion Date

April 30, 2019

Conditions
Cesarean SectionPostoperative Pain
Interventions
DRUG

0.25 mg/kg of Ketamine

patients will recieve 0.25mg/kg of ketamine intravenously 5 min after spinal anesthesia

DRUG

20ml of normal saline solution

20ml of normal saline solution intravenously 5 minutes after spinal anesthesia

Trial Locations (1)

2046

Mongi Slim University Hospital, La Marsa

All Listed Sponsors
lead

Mongi Slim Hospital

OTHER

NCT04545801 - Ketamine for Analgesia After Cesarean Section | Biotech Hunter | Biotech Hunter